Avid Bioservices has appointed Richard Richieri as chief operations officer. In this role, Mr. Richieri will oversee process development, clinical and commercial manufacturing, technical support and facilities.
 
Mr. Richieri has over 25 years of biopharmaceutical industry experience spanning the areas of drug discovery, CGMP operations, contract manufacturing and process development. Mr. Richieri previously spent 15 years with Avid Bioservices and its former parent company, Peregrine Pharmaceuticals, including the role of senior vice president of manufacturing. During that time, he was instrumental in launching, building and growing Avid’s CDMO business and helping the company diversify its production capabilities. He spent the past five years serving as an advisor and acting head of biologics production for Syngene International, a global discovery, development and manufacturing organization serving the pharmaceutical industry.
 
“We are very pleased to welcome Rich back to Avid and look forward to the important contributions that he will make to continuing Avid’s record of delivering excellent CDMO services to our clients,” said Rick Hancock, interim president and chief executive officer, Avid. “Rich’s extensive history with the company, combined with his more recent experience working with a wide range of innovator companies and international biologics CDMOs, represents a unique, highly specialized skill set that will be extremely valuable to Avid’s growth and development.”